Nestlé – DBV agreement for tests on allergies to cow’s milk

Nestlé today announced an agreement with the Franco-American company DBV Technologies for the development of a test to diagnose children with allergy to cow's milk proteins.

DBV, with offices in Montrouge and New York, will receive from Nestlé up to 100 million euro on the arc of the different stages of research and new product registration, specifying the two companies said in a statement today. Allergy against the cow's milk concerns 2-3% of infants and young children. The process of approval of the new test should be started in 2021.

This investment demonstrates the desire of Nestle to expand the activities of its health division, Nestlé Health Science. The group intends to bring sales of the fund to 10 billion francs.
The news of the agreement prompted the title DBV Technologies in the morning than in Paris earns 2.5%.